Evidence map›Paper›PMID 12163570›Full record

ArticleJournal of virology2002

Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.

Ana Maria Contreras, Yoichi Hiasa, Wenping He, Adam Terella, Emmett V Schmidt, Raymond T Chung

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 190 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Evaluation of anti-HIV-1 mutagenic nucleoside analogues.The Journal of biological chemistry · 2015
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana Maria ContrerasGastrointestinal Unit, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114, USA.
Yoichi Hiasa
Wenping He
Adam Terella
Emmett V Schmidt
Raymond T Chung
Harvard University · US

Funding

The effect of curcumin on age-related cognitive decline in the rhesus monkeyR01AG043478 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MOSS, MARK BARRY · 2013 to 2017
$2.9M
NOVEL ANIMAL MODELS OF HCV-RELATED HEPATOCARCINOGENESISR01DK057857 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHUNG, RAYMOND T · 1999 to 2003
$1.2M
HEPATITIS C TRANSGENIC MICE AS MODEL OF LIVER INJURYR01AI043478 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SCHMIDT, EMMETT VANCE · 1998 to 2000
$319k
NIAID NIH HHS R01 AI43478NIA NIH HHS R01 AG043478NIDDK NIH HHS R01 DK057857NIDDK NIH HHS R01 DK 57857
6 · The paper itself

Abstract

High rates of genetic variation ensure the survival of RNA viruses. Although this variation is thought to result from error-prone replication, RNA viruses must also maintain highly conserved genomic segments. A balance between conserved and variable viral elements is especially important in order for viruses to avoid "error catastrophe." Ribavirin has been shown to induce error catastrophe in other RNA viruses. We therefore used a novel hepatitis C virus (HCV) replication system to determine relative mutation frequencies in variable and conserved regions of the HCV genome, and we further evaluated these frequencies in response to ribavirin. We sequenced the 5' untranslated region (5' UTR) and the core, E2 HVR-1, NS5A, and NS5B regions of replicating HCV RNA isolated from cells transfected with a T7 polymerase-driven full-length HCV cDNA plasmid containing a cis-acting hepatitis delta virus ribozyme to control 3' cleavage. We found quasispecies in the E2 HVR-1 and NS5B regions of untreated replicating viral RNAs but not in conserved 5' UTR, core, or NS5A regions, demonstrating that important cis elements regulate mutation rates within specific viral segments. Neither T7-driven replication nor sequencing artifacts produced these nucleotide substitutions in control experiments. Ribavirin broadly increased error generation, especially in otherwise invariant regions, indicating that it acts as an HCV RNA mutagen in vivo. Similar results were obtained in hepatocyte-derived cell lines. These results demonstrate the potential utility of our system for the study of intrinsic factors regulating genetic variation in HCV. Our results further suggest that ribavirin acts clinically by promoting nonviable HCV RNA mutation rates. Finally, the latter result suggests that our replication model may be useful for identifying agents capable of driving replicating virus into error catastrophe.

Indexed as

Amino Acid SequenceAntiviral AgentsBase SequenceCell LineGene Expression Regulation, ViralGenetic VariationHepacivirusHumansInterferon-alphaMutationRibavirinRNA, ViralVirus ReplicationAntiviral AgentsInterferon-alphaRibavirinRNA, Viral

Identifiers

PMID12163570
PMCPMC136407
OpenAlexW2039884199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.